by Biolexis | Nov 29, 2023 | Press Releases
Led by Clarke Capital, the new funding round will accelerate the company’s drug discovery pipeline American Fork, UT – November 29, 2023— Biolexis Therapeutics, Inc., a clinical stage AI-driven drug discovery company, announced today the successful...
by Biolexis | Oct 26, 2023 | News & Media, Press Releases
October 26, 2023 Biolexis Therapeutics, a clinical-stage AI-enabled drug discovery company, today announced the launch of Metabolexis, a new pipeline company developing three targeted oral small molecules for the treatment of Obesity and Type 2 Diabetes, with the...